Spanish healthcare acquisition in jeopardy

(February 28, 2011) -- The Commission may challenge Grifols SA planned purchase of Talecris Biotherapeutics “on fears the merger would reduce supplies and raise prices for medicines to treat a range of autoimmune disorders,” according to a Reuters report....

Related Sections